Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 42,220 | 29,349 | 16,985 | 22,761 | 10,661 |
| Cost of Goods | 61,291 | 39,504 | 42,195 | 29,164 | 6,361 |
| Gross Profit | -19,072 | -10,155 | -25,209 | -6,404 | 4,300 |
| Operating Expenses | 46,135 | 31,773 | 35,274 | 33,071 | 21,991 |
| Operating Income | -64,915 | -41,424 | -60,289 | -39,310 | -17,330 |
| Interest Expense | 11,985 | 8,993 | 5,523 | 3,286 | 2,240 |
| Other Income | 1,151 | 2,138 | 68 | -1,163 | 55 |
| Pre-tax Income | -75,749 | -48,279 | -65,743 | -43,759 | -19,515 |
| Net Income Continuous | -75,749 | -48,279 | -65,743 | -43,759 | -19,515 |
| Net Income | $-75,749 | $-48,279 | $-65,743 | $-43,759 | $-19,515 |
| EPS Basic Total Ops | -0.88 | -0.89 | -1.45 | -1.91 | -1.61 |
| EPS Basic Continuous Ops | -0.88 | -0.89 | -1.45 | -1.91 | -1.61 |
| EPS Diluted Total Ops | -0.88 | -0.89 | -1.45 | -1.91 | -1.61 |
| EPS Diluted Continuous Ops | -0.88 | -0.89 | -1.45 | -1.91 | -1.61 |
| EPS Diluted Before Non-Recurring Items | -0.88 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-59,333 | $-37,129 | $-55,881 | $-35,979 | $-16,327 |